A lipoprotein mutant of E. coli K-12 has been characterized. The mutant lipoprotein was found to differ from the wild-type lipoprotein in the following respects: (i) it is present in an appreciable amount in the soluble fraction (275,000 X g supernatant); (ii) it lacks the covalently-linked diglyceride; (iii) it contains an unmodified cysteine which can be carboxymethylated in vitro; (iv) it undergoes dimerization and the dimer can be converted into monomeric form by reduction with 2-mercaptoethanol; (v) both the monomeric form and especially the dimeric form of the mutant lipoprotein migrate more slowly than the corresponding forms of wild-type lipoprotein in sodium dodecyl sulfate/urea polyacrylamide gel electrophoresis; and (vi) the mutant lipoprotein is not assembled into the murein sacculi, and this results in a greatly reduced amount of boundform lipoprotein in the mutant. These data strongly suggest that the mutation has affected the primary structure of lipoprotein, in such a way that it is not modified normally, leafing to the production of a structurally-altered lipoprotein deficient in covalently-linked lipid as well as a defective assembly of the altered lipoprotein into the rigid layer of the cell envelope.
The cell envelopes of Escherichia coli contain a major protein, the murein lipoprotein as discovered by Braun and his coworkers (1) . This lipoprotein is present in the outer membrane of the cell envelope in two forms, free and bound; the bound form is attached to the meso-diaminopimelic acid residues in the murein sacculus through the E-NH2 group of the COOHterminal lysine of the lipoprotein (2) (3) (4) . The primary structure of this lipoprotein has been determined (5) . The NH2-terminus of the lipoprotein is a novel lipoamino acid with three fatty-acyl residues covalently attached to glycerylcysteine. Two of the fatty'acids are-linked to the hydroxyl groups of the glycerylcysteine by ester linkages, and the third is attached through amide linkage to the a-NH2 group of glycerylcysteine (6) .
In an attempt to define the biochemical mechanisms for the biosynthesis and assembly of murein lipoprotein in E. coli (7), we have isolated E. coli mutants defective in the biosynthesis and/or assembly of murein lipoprotein. In a previous report, we presented preliminary evidence for the presence of a structurally-altered lipoprotein in one of the mutants we have isolated (8) . This mutant is strikingly different from the wildtype strain by its extremely low content of the murein-bound lipoprotein (bound form). In this paper, we present further evidence that suggests this mutant is affected in SuIIIA81t , his pro mlpA-) as described (8) . E. coli strains JE5512 (Hfr Cavalli man-lpm + pps-) and JE5511 (Hfr CaAbbreviation: NaDodSO4, sodium dodecyl sulfate.
valli man -lpm -pps-) were the generous gift of Y. Hirota, National Institute of Genetics, Japan. Media used in the present study included protease peptone beef extract broth and M9 minimal medium (7) .
Biochemical Techniques. Procedures used for the labeling of bacterial cells, preparation of cell envelope, and the identification of both the free and bound forms of murein lipoprotein by both immunological and biochemical techniques have been described (7, 8) . Sodium dodecyl sulfate (NaDodSO4)/polyacrylamide gel electrophoresis was carried out as described (9) . Polyacrylamide gel electrophoresis was also carried out in NaDodSO4 and urea according to the procedure of Swank and Munkres (10) .
Performic acid oxidation of the purified free form of lipoprotein was carried out according to Hirs (11) . Hydrolysis of lipoprotein was carried out in 6 M HCO at 1050 for 20 hr in sealed, evacuated tubes. Amino acid analysis was performed with a Beckman model 120 C amino acid analyzer equipped for determination of amino acids in the range of 7.5-30 nmol (12) . An acidic amino acid, migrating between cysteic acid and L-aspartic acid, was assumed to be glycerylcysteine sulfone.
Carboxymethylation of Envelope' Proteins. Envelope proteins labeled with [3H]arginine were solubilized with 0.4 ml 0.01 M sodium phosphate buffer (pH 7.0) containing 1% NaDodSO4 and 1% 2-mercaptoethanol. After incubation at 370 for 2 hr, the envelope proteins were precipitated with acetone at a final concentration of 80% (vol/vol). The precipitate was recovered by centrifugation at 12,000 X g for 10 min and washed once with 2 ml of 80% acetone. The washed precipitate was solubilized in 0.4 ml of 0.01 M sodium phosphate (pH 7.0) containing 1% NaDodSO4. ['4C]Iodoacetic acid (16 , uCi , specific activity of 6 ,uCi/,umol) was added to the reduced envelope proteins. The reaction mixture was incubated at 370 for 2 hr in a test tube wrapped with aluminum foil. The reaction was terminated by the addition of 20 ,ul of 2-mercaptoethanol. Acetone (1.6 ml) was added to precipitate the envelope proteins. The acetone precipitate was washed once with 80% acetone and then solubilized in 0.01 M sodium phosphate (pH 7.0) containing 1% NaDodSO4.
Chemicals and Radiochemicals. All chemicals were of reagent grade and were purchased from commercial sources. Radioactive chemicals used in the present study included [2- (17) . Fig. 4 shows that lipoprotein from mutant 3 can also undergo dimerization in the absence of SH-reducing agent. While both the reduced and unreduced lipoprotein from the wild-type strain showed the same electrophoretic mobilities in NaDodSO4/urea gel, the reduced form of mutant lipoprotein showed a greatly increased mobility in NaDodSO4/urea gel compared with the unreduced form. This is consistent with an intermolecular disulfide bridge between the unmodified cysteine present in the mutant lipoprotein.
(iv) Direct amino acid analysis of lipoprotein purified from wild-type strain E600 To investigate the second possibility, we compared the lipoprotein from mutant 3 with Ipm -mutant of Suzuki et al., because the Ipm -strain was reported to contain lipid-deficient lipoprotein (17) . Fig. 5 shows both the dimeric and the monomeric forms of lipoprotein from mutant 3 migrated more slowly than the corresponding dimer and monomer lipoprotein in the Ipm-mutant. Based on the molecular weight calibration curve shown in Fig. 6 , the apparent molecular weight of the lipoprotein in mutant 3 would appear to be approximately 9,000-11,000.
While the lipoprotein in the 1pm-mutant might be lipiddeficient, its assembly into the murein sacculi appeared to be unaffected (17) . The data in Table 2 show a striking difference in the assembly of murein-bound lipoprotein in mutant 3 compared with that of the Ipm -mutant. It strongly suggests that there is structural difference(s) between the lipoprotein from mutant 3 and that from Ipm -mutant, which is responsible for the defective assembly of murein-bound lipoprotein in mutant 3.
Final proof of our working hypothesis that the mutant lipoprotein contains extra amino acids at either the NH2-terminus, the COOH terminus or both, awaits elucidation of the primary structure of the mutant lipoprotein. Automated Edman degradation studies clearly indicate that the N terminus of the mutant lipoprotein is blocked (J. Ozols, C. Gerard, H. C. Wu, and D. R. Howlett, unpublished data). Carboxypeptidase B treatment releases lysine and arginine from the wild-type lipoprotein but only lysine from the mutant lipoprotein (J. Ozols, H. C. Wu, and D. R. Howlett, unpublished data). In addition, amino acid analysis has revealed significant qnd reproducible differences between the mutant lipoprotein and that of the wild type. The mutant lipoprotein contains extra isoleucine, leucine, (18) . It now appears very likely that the primary translation product of the lipoprotein gene is a polypeptide of an apparent molecular weight of 15,000. One of two reactions is likely to follow: (i) transfer of the diglyceride moiety from glycerophosphatides to the sulfhydryl group of the cysteine residue which ultimately becomes the NH2-terminal amino acid of the lipoprotein; and (ii) proteolytic processing of the prolipoprotein to the final product of approximately half size. Two additional modifications will take place: N-acylation of the NH2-terminal cysteine, and the joining of the free form lipoprotein to the murein sacculus through a peptide bond between the diaminopimelic acid and the E-NH2 of the COOH-terminal lysine.
The data presented in this paper strongly suggest that mutant 3 is altered in the structural gene for lipoprotein in 
